Showing 1 - 20 results of 25 for search 'Simona Di Giambenedetto', query time: 0.05s Refine Results
  1. 1
    Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice

    Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice by Simone Belmonti, Simona Di Giambenedetto, Francesca Lombardi

    Published 2021-12-01
    Get full text
    Article
  2. 2
    Encephalopathy as neurological involvement of SARS-COV-2 infection

    Encephalopathy as neurological involvement of SARS-COV-2 infection by Maria Rita Lo Monaco, Simona Di Giambenedetto, Anna Maria Martone, Katleen De Gaetano Donati, Francesco Landi

    Published 2020-10-01
    Get full text
    Article
  3. 3
    Ventilator-associated pneumonia (VAP) and pleural empyema caused by multidrug-resistant Acinetobacter baumannii in HIV and COVID 19 infected patient: A case report

    Ventilator-associated pneumonia (VAP) and pleural empyema caused by multidrug-resistant Acinetobacter baumannii in HIV and COVID 19 infected patient: A case report by Rosa Anna Passerotto, Francesco Lamanna, Damiano Farinacci, Alex Dusina, Simona Di Giambenedetto, Arturo Ciccullo, Alberto Borghetti

    Published 2023-06-01
    Get full text
    Article
  4. 4
    Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients

    Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-inf... by Francesca Lombardi, Simone Belmonti, Alberto Borghetti, Arturo Ciccullo, Gianmaria Baldin, Roberto Cauda, Massimiliano Fabbiani, Simona Di Giambenedetto

    Published 2019-05-01
    Get full text
    Article
  5. 5
    Inflammation markers in virologically suppressed HIV-Infected patients after switching to dolutegravir plus lamivudine vs continuing triple therapy: 48-week results in real-life setting

    Inflammation markers in virologically suppressed HIV-Infected patients after switching to dolutegravir plus lamivudine vs continuing triple therapy: 48-week results in real-life se... by Francesca Lombardi, Simone Belmonti, Davide Moschese, Massimiliano Fabbiani, Alberto Borghetti, Arturo Ciccullo, Elena Visconti, Simona Di Giambenedetto

    Published 2022-12-01
    Get full text
    Article
  6. 6
    The threshold bootstrap clustering: a new approach to find families or transmission clusters within molecular quasispecies.

    The threshold bootstrap clustering: a new approach to find families or transmission clusters within molecular quasispecies. by Mattia C F Prosperi, Andrea De Luca, Simona Di Giambenedetto, Laura Bracciale, Massimiliano Fabbiani, Roberto Cauda, Marco Salemi

    Published 2010-10-01
    Get full text
    Article
  7. 7
    Clinical presentation of human monkeypox virus infection during the 2022 outbreak: descriptive case series from a large italian Research Hospital

    Clinical presentation of human monkeypox virus infection during the 2022 outbreak: descriptive case series from a large italian Research Hospital by Pierluigi Francesco Salvo, Damiano Farinacci, Francesca Lombardi, Arturo Ciccullo, Enrica Tamburrini, Rosaria Santangelo, Alberto Borghetti, Simona Di Giambenedetto

    Published 2023-09-01
    Get full text
    Article
  8. 8
    Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections

    Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections by Simona Di Giambenedetto, Alberto Borghetti, Lorena Quagliozzi, Valeria Gallucci, Francesca Lombardi, Arturo Ciccullo, Anna Fagotti, Enrica Tamburrini, Giovanni Scambia

    Published 2022-04-01
    Get full text
    Article
  9. 9
    Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study

    Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study by Filippo Lagi, Annarita Botta, Arturo Ciccullo, Chiara Picarelli, Massimiliano Fabbiani, Simona di Giambenedetto, Vanni Borghi, Cristina Mussini, Alessandro Bartoloni, Gaetana Sterrantino

    Published 2021-09-01
    Get full text
    Article
  10. 10
    Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study.

    Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Cont... by Francesca Lombardi, Simone Belmonti, Massimiliano Fabbiani, Matteo Morandi, Barbara Rossetti, Giacinta Tordini, Roberto Cauda, Andrea De Luca, Simona Di Giambenedetto, Francesca Montagnani

    Published 2016-01-01
    Get full text
    Article
  11. 11
    Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Rome, Italy during the COVID-19 Outbreak

    Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Rome, Italy during the COVID-19 Outbreak by Francesca Lombardi, Rosalba Ricci, Simone Belmonti, Massimiliano Fabbiani, Alberto Borghetti, Gianmaria Baldin, Arturo Ciccullo, Enrica Tamburrini, Elena Visconti, Maurizio Sanguinetti, Simona Di Giambenedetto

    Published 2021-06-01
    Get full text
    Article
  12. 12
    Changes in Metabolic Profile in PLWHIV Switching to Doravirine-Based Regimen

    Changes in Metabolic Profile in PLWHIV Switching to Doravirine-Based Regimen by Valentina Iannone, Rosa Anna Passerotto, Francesco Lamanna, Rebecca Jo Steiner, Francesca Lombardi, Pierluigi Francesco Salvo, Alex Dusina, Damiano Farinacci, Alberto Borghetti, Simona Di Giambenedetto, Arturo Ciccullo

    Published 2023-04-01
    Get full text
    Article
  13. 13
    Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice

    Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study... by Alberto Borghetti, Francesca Lombardi, Roberta Gagliardini, Gianmaria Baldin, Arturo Ciccullo, Davide Moschese, Arianna Emiliozzi, Simone Belmonti, Silvia Lamonica, Francesca Montagnani, Elena Visconti, Andrea De Luca, Simona Di Giambenedetto

    Published 2019-01-01
    Get full text
    Article
  14. 14
    Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic Study

    Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic Study by Jessica Cusato, Alberto Borghetti, Elisabetta Teti, Maurizio Milesi, Maria Cristina Tettoni, Stefano Bonora, Mattia Trunfio, Antonio D’Avolio, Mirko Compagno, Simona Di Giambenedetto, Giovanni Di Perri, Andrea Calcagno

    Published 2022-12-01
    Get full text
    Article
  15. 15
    Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort.

    Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort. by Amedeo F Capetti, Gaetana Sterrantino, Maria Vittoria Cossu, GianCarlo Orofino, Giorgio Barbarini, Giuseppe V De Socio, Simona Di Giambenedetto, Antonio Di Biagio, Benedetto M Celesia, Barbara Argenteri, Giuliano Rizzardini

    Published 2016-01-01
    Get full text
    Article
  16. 16
    Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART.

    Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART. by Giuseppe Lapadula, Liliane Chatenoud, Andrea Gori, Francesco Castelli, Simona Di Giambenedetto, Massimiliano Fabbiani, Franco Maggiolo, Emanuele Focà, Nicoletta Ladisa, Laura Sighinolfi, Massimo Di Pietro, Angelo Pan, Carlo Torti, Italian MASTER Cohort

    Published 2015-01-01
    Get full text
    Article
  17. 17
    Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype

    Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype by Pierluigi Francesco Salvo, Damiano Farinacci, Arturo Ciccullo, Vanni Borghi, Stefano Rusconi, Annalisa Saracino, William Gennari, Bianca Bruzzone, Ilaria Vicenti, Annapaola Callegaro, Antonio Di Biagio, Maurizio Zazzi, Simona Di Giambenedetto, Alberto Borghetti

    Published 2023-03-01
    Get full text
    Article
  18. 18
    Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.

    Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus. by Cristina Mussini, Patrizia Lorenzini, Massimo Puoti, Miriam Lichtner, Giuseppe Lapadula, Simona Di Giambenedetto, Andrea Antinori, Giordano Madeddu, Alessandro Cozzi-Lepri, Antonella d'Arminio Monforte, Andrea De Luca, ICONA Foundation Study Group

    Published 2015-01-01
    Get full text
    Article
  19. 19
    Correction: Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models.

    Correction: Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models. by Mattia C. F. Prosperi, Michal Rosen-Zvi, André Altmann, Maurizio Zazzi, Simona Di Giambenedetto, Rolf Kaiser, Eugen Schülter, Daniel Struck, Peter Sloot, David A. van de Vijver, Anne-Mieke Vandamme, Anders Sönnerborg

    Published 2011-01-01
    Get full text
    Article
  20. 20
    Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients

    Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients by Massimiliano Fabbiani, Melissa Masini, Barbara Rossetti, Arturo Ciccullo, Vanni Borghi, Filippo Lagi, Amedeo Capetti, Manuela Colafigli, Francesca Panza, Gianmaria Baldin, Cristina Mussini, Gaetana Sterrantino, Damiano Farinacci, Francesca Montagnani, Mario Tumbarello, Simona Di Giambenedetto

    Published 2023-05-01
    Get full text
    Article

Search Tools: